Minimally invasive intrauterine interventions: a review of their use in the prevention of pregnancy complications in case of premature discharge of amniotic fluid and rupture of the amniotic membrane during fetoscopic interventions

封面


如何引用文章

全文:

详细

This review article highlights the results of using the variety of methods to prevent premature discharge of amniotic fluid as a complication of minimally invasive intrauterine interventions: the imposition of tissue sealant and amniopatch; amnioinfusion with normal saline, Ringer’s solution or artificial amniotic fluid using a port system. A historical background is given on the application of these correction methods.

作者简介

Natalya Kosovtsova

Urals Scientific Research Institute for Maternal and Child Care

编辑信件的主要联系方式.
Email: kosovcovan@mail.ru

MD, PhD, DSci (Medicine), Leading Researcher, the Head of the Department of Biophysical and Radiation Research

俄罗斯联邦, Ekaterinburg

Tatyana Putilova

Urals Scientific Research Institute for Maternal and Child Care

Email: putilova.t@yandex.ru

MD, PhD

俄罗斯联邦, Ekaterinburg

Maria Pavlichenko

Urals Scientific Research Institute for Maternal and Child Care

Email: omm@k66.ru

MD, PhD, the Head of the Young Children Department

俄罗斯联邦, Ekaterinburg

Tatyana Markova

Urals Scientific Research Institute for Maternal and Child Care

Email: ta.ma.vl@mail.ru

MD, PhD, Senior Researcher

俄罗斯联邦, Ekaterinburg

参考

  1. Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet. 2008;371(9606):75-84. https://doi.org/10.1016/s0140-6736(08)60074-4.
  2. Дятлова Л.И. Факторы риска преждевременного излития околоплодных вод при беременности 22–34 недели // Международный журнал экспериментального образования. – 2015. – № 4-2. – С. 318–322. [Dyatlova LI. Risk factors for premature rupture of membranes in pregnancy 22-34 weeks. Mezhdunarodnyy zhurnal eksperimental’nogo obrazovaniya. 2015;(4-2):318-322. (In Russ.)]
  3. Шнейдерман М.Г., Фатхудинов Т.Х., Тетруашвили Н.К., и др. Способ герметизации ятрогенных повреждений плодных оболочек при проведении фетальных хирургических вмешательств // Гинекология. – 2018. – Т. 20. – № 1. – С. 84–87. [Shneyderman MG, Fatkhudinov TKh, Tetruashvili NK, et al. The method of hermetic sealing of iatrogenic damage of fetal membranes during fetal surgical interventions. Ginekologiya. 2018;20(1):84-87. (In Russ.)]
  4. Quintero RA, Kontopoulos EV, Chmait R, et al. Management of twin-twin transfusion syndrome in pregnancies with iatrogenic detachment of membranes following therapeutic amniocentesis and the role of interim amniopatch. Ultrasound Obstet Gynecol. 2005;26(6):628-633. https://doi.org/10.1002/uog.2600.
  5. Quintero RA, Morales WJ, Allen M, et al. Treatment of iatrogenic previable premature rupture of membranes with intra-amniotic injection of platelets and cryoprecipitate (amniopatch): Preliminary experience. Am J Obstet Gynecol. 1999;181(3):744-749. https://doi.org/10.1016/s0002-9378(99)70522-3.
  6. Cobo T, Borrell A, Fortuny A, et al. Treatment with amniopatch of premature rupture of membranes after first-trimester chorionic villus sampling. Prenatal Diagnosis. 2007;27(11):1024-1027. https://doi.org/10.1002/pd.1825.
  7. Young BK, Mackenzie AP, Roman AS, et al. Endoscopic closure of fetal membrane defects: comparing iatrogenic versus spontaneous rupture cases. J Matern Fetal Neonatal Med. 2004;16(4):235-240. https://doi.org/10.1080/ 14767050400014774.
  8. Pathak B, Khan A, Assaf SA, et al. Amniopatch as a treatment for rupture of membranes following laser surgery for twin-twin transfusion syndrome. Fetal Diagn Ther. 2010;27(3):134-137. https://doi.org/10.1159/000275685.
  9. Sipurzynski-Budrass S, Macher S, Haeusler M, Lanzer G. Successful treatment of premature rupture of membranes after genetic amniocentesis by intra-amniotic injection of platelets and cryoprecipitate (amniopatch): A case report. Vox Sang. 2006;91(1):88-90. https://doi.org/10.1111/j.1423-0410.2006.00784.x.
  10. Deprest J, Van Mieghem T, Emonds MP, et al. Amniopatch to treat iatrogenic rupture of the fetal membranes. Gynecol Obstet Fertil. 2011;39(6):378-382. https://doi.org/10.1016/j.gyobfe.2011.04.010.
  11. Richter J, Henry A, Ryan G, et al. Amniopatch procedure after previable iatrogenic rupture of the membranes: A two-center review. Prenat Diagn. 2013;33(4):391-396. https://doi.org/10.1002/pd.4080.
  12. Kwak HM, Choi HJ, Cha HH, et al. Amniopatch treatment for spontaneous previable, preterm premature rupture of membranes associated or not with incompetent cervix. Fetal Diagn Ther. 2013;33(1):47-54. https://doi.org/10.1159/000342418.
  13. Ferianec V, Krizko M, Jr, Papcun P, et al. Amniopatch — possibility of successful treatment of spontaneous previable rupture of membranes in the second trimester of pregnancy by transabdominal intraamiotic application of platelets and cryoprecipitate. Neuro Endocrinol Lett. 2011;32(4):449-452.
  14. Sung JH, Kuk JY, Cha HH, et al. Amniopatch treatment for preterm premature rupture of membranes before 23 weeksʼ gestation and factors associated with its success. Taiwan J Obstet Gynecol. 2017;56(5):599-605. https://doi.org/10.1016/j.tjog.2017.08.005.
  15. Tchirikov M, Steetskamp J, Hohmann M, Koelbl H. Long-term amnioinfusion through a subcutaneously implanted amniotic fluid replacement port system for treatment of PPROM in humans. Eur J Obstet Gynecol Reprod Biol. 2010;152(1):30-33. https://doi.org/10.1016/j.ejogrb.2010.04.023.
  16. De Santis M, Scavo M, Noia G, et al. Transabdominal amnioinfusion treatment of severe oligohydramnios in preterm premature rupture of membranes at less than 26 gestational weeks. Fetal Diagn Ther. 2003;18(6):412-417. https://doi.org/10.1159/000073134.
  17. Turgut A, Katar S, Sak ME, et al. Continuous amnioinfusion via an epidural catheter following spontaneous membrane rupture: A case report. J Turk Ger Gynecol Assoc. 2013;14(4):238-241. https://doi.org/10.5152/jtgga.2013.53367.
  18. Tchirikov M, Bapayeva G, Zhumadilov Z, et al. Treatment of PPROM with anhydramnion in humans: first experience with different amniotic fluid substitutes for continuous amnioinfusion through a subcutaneously implanted port system. J Perinat Med. 2013;41(6):657-663. https://doi.org/10.1515/jpm-2012-0296.
  19. Tchirikov M, Zhumadilov Z, Winarno AS, et al. Treatment of preterm premature rupture of membranes with oligo-/anhydramnion colonized by multiresistant bacteria with continuous amnioinfusion and antibiotic administrations through a subcutaneously implanted intrauterine port system: A case report. Fetal Diagn Ther. 2017;42(1):71-76. https://doi.org/10.1159/000438483.
  20. Al Riyami N, Al-Ruheili I, Al-Shezaw F, Al-Khabori M. Extreme preterm premature rupture of membranes: risk factors and feto maternal outcomes. Oman Med J. 2013;28(2):108-111. https://doi.org/10.5001/omj.2013.28.
  21. Schucker JL, Mercer BM. Midtrimester premature rupture of the membranes. Semin Perinatol. 1996;20(5):389-400. https://doi.org/10.1016/s0146-0005(96)80006-1.
  22. Цхай В.Б., Набережнев Ю.И., Дудина А.Ю., Головченко О.В. Возможности и перспективы применения трансабдоминальной амниоинфузии для пролонгирования беременности при преждевременном разрыве плодных оболочек и маловодии // Акушерство и гинекология. – 2016. – № 11. – C. 5–10. [Tskhay VB, Naberezhnev YI, Dudina AY, Golovchenko OV. Transabdominal amnioinfusion for prolongation of pregnancy in premature rupture of membranes and hypamnion: possibilities and prospects. Akush Ginekol (Mosk). 2016;(11):5-10. (In Russ.)]. https://doi.org/10.18565/aig.2016.11.5-10.
  23. Набережнев Ю.И., Головченко О.В., Орлова В.С. Фетальная титановая порт-система в лечении акушерской патологии // Научные ведомости. – Серия «Медицина. Фармация». – 2012. – № 22. – C. 187–190. [Naberezhnev YI, Golovchenko OV, Orlova VS. Fetal’naya titanovaya port-sistema v lechenii akusherskoy patologii. Medicine, pharmacy. 2012;(22):187-190. (In Russ.)]
  24. Souza AS, Patriota AF, Guerra GV, Melo BC. Evaluation of perinatal outcomes in pregnant women with preterm premature rupture of membranes. Rev Assoc Med Bras (1992). 2016;62(3):269-275. https://doi.org/10.1590/1806-9282.62.03.269.
  25. Цхай В.Б., Набережнев Ю.И., Чириков М.Н., и др. Применение метода непрерывной амниоинфузии с использованием подкожной порт-системы при преждевременном разрыве плодных оболочек при сроке беременности менее 28 недель. Первый опыт в России // Акушерство и гинекология. – 2017. – № 12. – C. 141–147. [Tskhai VB, Naberezhnev YI, Chirikov MN, et al. Application of continuous amnioinfusion via a subcutaneous port system for premature rupture of membranes and at less than 28 weeks of gestation. The first experience in Russia. Obstetrics and Gynecology. 2017;(12):141-147. (In Russ.)]. https://doi.org/10.18565/aig.2017.12.141-147.
  26. Мальгина Г.Б., Башмакова Н.В., Шафиева К.А., Косовцова Н.В. Преждевременный разрыв плодных оболочек в сроке сверхранних преждевременных родов: факторы риска, акушерская тактика и перинатальные исходы // Российский вестник акушера-гинеколога. – 2014. – Т. 14. – № 6. – C. 60–64. [Mal’gina GB, Bashmakova NV, Shafieva KA, Kosovtsova NV. Very preterm premature rupture of membranes: Risk factors, obstetric tactics, and perinatal outcomes. Rossiiskii vestnik akushera-ginekologa. 2014;14(6):60-64. (In Russ.)]
  27. Mercer BM. Antibiotic Therapy for reduction of infant morbidity after preterm premature rupture of the membranes. Jama. 1997;278(12):989. https://doi.org/10.1001/jama.1997.03550120049032.
  28. van der Heyden JL, van Kuijk SM, van der Ham DP, et al. Subsequent pregnancy after preterm prelabor rupture of membranes before 27 weeksʼ gestation. AJP Rep. 2013;3(2):113-118. https://doi.org/10.1055/s-0033-1353389.
  29. Porat S, Amsalem H, Shah PS, Murphy KE. Transabdominal amnioinfusion for preterm premature rupture of membranes: a systematic review and meta-analysis of randomized and observational studies. Am J Obstet Gynecol. 2012;207(5):393 e391-311. https://doi.org/10.1016/j.ajog. 2012.08.003.
  30. Turgut A, Katar S, Sak ME, et al. Continuous amnioinfusion via an epidural catheter following spontaneous membrane rupture: A case report. J Turk Ger Gynecol Assoc. 2013;14(4):238-241. https://doi.org/10.5152/jtgga.2013.53367.
  31. Locatelli A, Andreani M, Ghidini A, et al. Amnioinfusion in preterm PROM: effects on amnion and cord histology. J Perinatol. 2008;28(2):97-101. https://doi.org/10.1038/sj.jp.7211876.
  32. Tyson RW, Staat BC. The intrauterine growth-restricted fetus and placenta evaluation. Semin Perinatol. 2008;32(3):166-171. https://doi.org/10.1053/j.semperi.2008.02.005.
  33. Richter J, Henry A, Ryan G, et al. Amniopatch procedure after previable iatrogenic rupture of the membranes: a two-center review. Prenat Diagn. 2013;33(4):391-396. https://doi.org/10.1002/pd.4080.
  34. Tyson RW. The intrauterine growth-restricted fetus and placenta evaluation. Semin Perinatol. 2008;32(3):166-171. doi: 10.1053/j.semperi.2008.02.005.
  35. Richter J, Henry A, Ryan G, et al. Amniopatch procedure after previable iatrogenic rupture of the membranes: a two-center review. Prenat Diagn. 2013;33(4):391-6. https://doi.org/10.1002/pd.40080.

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Kosovtsova N.V., Putilova T.A., Pavlichenko M.V., Markova T.V., 2019

Creative Commons License
此作品已接受知识共享署名 4.0国际许可协议的许可

Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).